Literature DB >> 17245346

Can tamoxifen therapy be optimized for patients with breast cancer on the basis of CYP2D6 activity assessments?

Chris H Takimoto1.   

Abstract

Entities:  

Year:  2007        PMID： 17245346     DOI： 10.1038/ncponc0716

Source DB:  PubMed          Journal:  Nat Clin Pract Oncol        ISSN： 1743-4254


× No keyword cloud information.
  2 in total

1.  Polymorphism of human cytochrome P450 2D6 and its clinical significance: part II.

Authors:  Shu-Feng Zhou
Journal:  Clin Pharmacokinet       Date:  2009       Impact factor: 6.447

Review 2.  PharmGKB summary: tamoxifen pathway, pharmacokinetics.

Authors:  Daniel J Klein; Caroline F Thorn; Zeruesenay Desta; David A Flockhart; Russ B Altman; Teri E Klein
Journal:  Pharmacogenet Genomics       Date:  2013-11       Impact factor: 2.089
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.